期刊文献+

肝癌组织中基质金属蛋白酶2、基质金属蛋白酶9和血管内皮生长因子的表达及临床意义 被引量:3

Expression of MMP - 2 , MMP - 9 and VEGF in hepatocellular carcinoma and its clinical significance
原文传递
导出
摘要 目的 探讨基质金属蛋白酶2( MMP-2)、基质金属蛋白酶9(MMP-9)和血管内皮生长因子(VEGF)在肝癌组织中的表达及其临床意义.方法 采用免疫组化SP法检测80例肝癌组织中MMP-2、MMP-9和VEGF表达情况,并以30例正常肝组织作为对照.结果 肝癌组织中MMP-2、MMP-9和VEGF表达均显著高于正常肝组织(x2=8.752,7.951,6.812,均P<0.05).肝癌患者中Ⅲ~Ⅳ期、淋巴结转移患者的MMP-2、MMP-9和VEGF阳性表达率分别高于Ⅰ~Ⅱ期和无淋巴结转移患者(x2 =6.124,5.262,5.834,5.653,5.932,6.785,均P<0.05).结论 肝癌组织中MMP-2、MMP-9和VEGF的表达水平明显升高,它们在肝癌的浸润转移中起到了重要的作用,可作为反映肝癌进展的生物学指标. Objective To analyze the correlation of MMP-2,MMP-9 and VEGF expression in hepatocellular carcinoma and to investigate the clinical significance.Methods The expression of MMP-2,MMP-9 and VEGF were measured by immunohistochemistry in the resected specimens from 80 patients with hepatocellular carcinoma and 30 controls.Results The positive rate of MMP-2,MMP-9 and VEGF were significantly higher in the hepatocellular carcinoma patients than those of controls( x2 =8.752,7.951,6.812,all P 〈 0.05).The positive rate of MMP-2,MMP-9 and VEGF in Ⅲ ~ Ⅳ stage was significantly higher than those of patients in Ⅰ ~ Ⅱ stage tumor( x2 =6.124,5.262,5.834,all P 〈0.05).The positive rate of MMP-2,MMP-9 and VEGF in lymph node metastasis tumor was significantly higher than those of patients in non metastasis tumor( x2 =5.653,5.932,6.785,all P 〈 0.05 ).Conclusion MMP-2,MMP-9and VEGF expression in hepatocellular carcinoma increased markedly and plays an important role in progression of hepatocellular carcinoma.
作者 申星杰
出处 《中国基层医药》 CAS 2011年第24期3338-3339,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肝肿瘤 基质金属蛋白酶2 基质金属蛋白酶9 血管内皮生长因子 免疫组织化学 Hepatocellular carcinoma MMP-2 MMP-9 VEGF Immunohistochemistry
  • 相关文献

参考文献10

二级参考文献70

共引文献127

同被引文献36

  • 1何东风,徐克,张曦彤,蒋宝国,邵海波,郭敏.兔VX2肝癌改良模型的建立及螺旋CT评价[J].中国医学影像技术,2005,21(12):1873-1876. 被引量:24
  • 2Vahola R, Salven P, Heikkila P. VEGFR-3 and its ligand VEGF- C are associated with angiogenesis in breast cancer. Am J Pathol, 1999,154(5) :1381.
  • 3Saaristo A, Partanen TA, Arola J, et al. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors. Am J Pathol,2000,157(1) :7-14.
  • 4Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor- C) VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol, 2005,12 ( 2 ) : 152.
  • 5Inoue K, Slaton JW, Karashima T, et al. The prognostic value and angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant cheinotherapy and redical cyctectomy. Clin Cancer Res,2000,6 (12) :4866-4873.
  • 6Ito Y,Kudo T,Takamura Y. Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age[J].World Journal of Surgery,2011,(12):2684-2690.
  • 7Ahmed M,Uddin S,Hussain AR. FoxM1 and Its Association with Matrix Metalloproteinases(MMP) Signaling Pathway in Papillary Thyroid Carcinoma[J].Journal of Clinical Endocrinology and Metabolism,2012,(01):E1-E13.
  • 8Bommarito A,Richiusa P,Carissimi E. BRAFV600E mutation,TIMP-1 upregulation,and NF-κB activation:closing the loop on the papillary thyroid cancer trilogy[J].Endocrine-Related Cancer,2011,(06):669-685.
  • 9Visse R,Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure,function,and biochemistry[J].Circulation Research,2003,(08):827-839.
  • 10Perigny M,Bairati I,Harvey I. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by overian cancer[J].American Journal of Clinical Pathology,2008,(02):226-231.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部